Search NASASearch

NASA NTRS · 20260004954

Final Report Document: Microgravity Medical Eyewash B

Abstract

Senior Capstone Design Team 15 has been commissioned by the National Aeronautics and Space Administration (NASA) to redesign the current microgravity eye wash station. The current design exhibits four primary limitations: single-use operation, excessive mass and volume, operational complexity requiring coordination with external systems, and dependence on frequent Earth resupply missions. Our updated eyewash design will be deployed on long-range space missions that could last multiple years. Based on these and other requirements from our customer, we have developed our updated eyewash design. Our compact, single-eye system uses capillary-driven flow and a free-floating water ball. This design allows us to eliminate pumps and bulky tubing, decreasing the mass and volume of the overall system. The containment eyecup is held to the astronaut's face with a strap, and a silicone seal prevents leakage while improving user comfort. Contaminated water is contained within a disposal bag containing wicking material to pull it back out of the eyecup after washing the eye. This system is reusable, efficient, and easy to activate quickly. We evaluated our design through calculations, microfluidic testing, and user try-on testing to verify our requirements. Our work demonstrated that steady-state flow was capable with our capillary framework, achieving 1.31 L/min. The prototype construction confirmed mass and volume reductions, and try-on-testing evaluated the ability to put on the system quickly. Almost all major design requirements were achieved, and water loss could be validated by testing in microgravity. Our design went through a number of iterations to reach the final solution presented in this report. These changes were driven by our testing and collaboration from each member of the team. Updated models optimized tube placement and geometry of the eyecup to better direct flow as it pools across the eye. Changes to our tubing bends improved capillary efficiency and increased the flow rate we were capable of achieving. And improved bracket placements adjusted the fit, comfort, and seal of the eyecup to the astronaut's face. Our capillary-based eyewash system is technically feasible and has been theoretically validated to operate effectively in microgravity conditions. Testing and analysis indicate that it can meet or exceed the required performance metrics, including flow rate and safety constraints. Overall, the design represents a viable alternative to current ISS-dependent eyewash systems for future space missions.

Keep this discovery

BibTeXRIS

Jeffrey Allen, Cody A Haney, Charley L Isham, Anish Krishnamurthy, Andrew J Van Lente, Bhisham N Sharma. 2026-04-22. Final Report Document: Microgravity Medical Eyewash B. https://ntrs.nasa.gov/citations/20260004954

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related discoveries

Microgravity Game Changers: Recent Accomplishments of Microgravity Assisted Materials Experiments on the ISS

This paper discusses important new materials, devices and technology produced in low-Earth orbit (LEO) that have been developed with funding from NASA’s In Space Production Applications (InSPA) Portfolio. In coordination with the International Space Station (ISS) National Laboratory, InSPA supports innovative small businesses and other research & development organizations to develop microgravity-assisted applications that make significant impacts in a wide variety of industries on Earth. These technology development efforts are using the microgravity of orbital space to overcome gravity-induced defects on Earth to create high-value products for terrestrial markets in the areas of semiconductors, pharmaceuticals, and communications. Through 24/7/365 operation on ISS for 25 years, coupled with commercial space transportation and services to, in, and from orbit, the microgravity environment has enabled pioneering science and significant commercial applications, including novel medical advances. World-leading researchers, innovators, and space payload developers provide compelling evidence through demonstrations on the ISS that materials processing in microgravity improves outcomes for a wide range of materials and products at all levels of the organization of matter, from quantum entities such as Bose-Einstein condensates, to crystals, alloys, composites, thin films, and photonics, to stem cells, medical diagnoses, medical treatments, and medical devices for humans. As of 2026, numerous examples proved by demonstration on ISS show the potential of these technologies in various fields. In this paper, a summary of four important experiments is presented.

microgravity medical devices

A Review of Medical Results of Gemini 7 and Related Flights

On August 23, 1966, a review of the medical findings of the fourteen day Gemini 7 mission and related flights was conducted. This review was organized at the request of Dr. George E. Mueller, Associate Administrator for Manned Space Flight, and consisted of presentations by the Principal Investigators of the Gemini Medical Flight Experiments and by the Director, Medical Research and Operations, Manned Spacecraft Center. This document is a compilation of the material presented at the review. The Principals cooperated most significantly by reviewing a transcription of a tape recording of their presentation, editing and providing a final version for publication. Without this most generous assistance, this document could not have been published. Table I, which follows immediately after this Introduction, is presented to acquaint the reader with the scope and sequence of medical measurements and experiments which were conducted during Project Gemini. This review was held prior to the conduct of the Gemini 11 and 12 missions, therefore, material derived from those flights is not included in this document.

E J McLaughlin